Combination therapy with WT1 peptide vaccine and temozolomide

Invention Grant

US09539299B2 Combination therapy with WT1 peptide vaccine and temozolomide 有权

Title translation: WT1肽疫苗和替莫唑胺联合治疗

Patent Title: Combination therapy with WT1 peptide vaccine and temozolomide
Patent Title (中): WT1肽疫苗和替莫唑胺联合治疗
Application No.: US13665597

Application Date: 2012-10-31
Publication No.: US09539299B2

Publication Date: 2017-01-10
Inventor: Haruo Sugiyama , Toshiki Yoshimine , Akihiro Tsuboi , Naoya Hashimoto
Applicant: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Applicant Address: JP Suita
Assignee: International Institute of Cancer Immunology, Inc.
Current Assignee: International Institute of Cancer Immunology, Inc.
Current Assignee Address: JP Suita
Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
Main IPC: C07K14/00
IPC: C07K14/00 ; A61K38/08 ; A61K31/495

Abstract:

The present invention relates to combination therapy for cancer with a WT1 peptide vaccine and temozolomide.

Abstract(Chinese):

本发明涉及具有WT1肽疫苗和替莫唑胺的癌症联合疗法。

Public/Granted literature

Information query

Espacenet

IPC分类:

C	化学；冶金
C07	有机化学
C07K	肽（含有β-内酰胺的肽入C07D；在分子中除了形成本身的肽环外不含有任何其他的肽键的环状二肽，如哌嗪-2,5-二酮入C07D；环肽型麦角生物碱入C07D519/02；单细胞蛋白质、酶入C12N；获得肽的基因工程方法入C12N15/00）
C07K14/00	具有多于20个氨基酸的肽；促胃液素；生长激素释放抑制因子；促黑激素；其衍生物